Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Epidermal stem cells have potential for personalized regenerative medicine but need careful handling to avoid cancer.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Mesenchymal Stem Cells (MSCs) are promising for multiple therapies, but more research is needed to fully understand and optimize their use.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

New single-cell analysis techniques are improving our understanding of stem cells and could help in treating diseases.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.